Jazz Pharmaceuticals to Announce Third Quarter Financial Results on November 5, 2009

Jazz Pharmaceuticals to Announce Third Quarter Financial Results on November
5, 2009

PALO ALTO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals,
Inc. (Nasdaq: JAZZ) today announced that it will report its third quarter 2009
financial results on Thursday, November 5, 2009. Jazz Pharmaceuticals will
host an investor conference call and live webcast to give a company update, as
well as to discuss financial results and guidance, on November 5, 2009, at
5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The live webcast and press release may be accessed from the Investors section
of the Jazz Pharmaceuticals' website at www.jazzpharmaceuticals.com. Please
connect to the website prior to the start of the conference call to ensure
adequate time for any software downloads that may be necessary to listen to
the webcast. An archived version of the webcast will be available through
November 19, 2009.

Investors may participate in the conference call by dialing 1-866-825-1692 in
the U.S., or 1-617-213-8059 outside the U.S., and entering passcode 25459996.

About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies,
develops and commercializes innovative treatments for important, underserved
markets in neurology and psychiatry. For further information please see
www.jazzpharmaceuticals.com.

SOURCE Jazz Pharmaceuticals, Inc.

Willie Quinn, Executive Director, Corporate Development of Jazz
Pharmaceuticals, Inc., investorinfo@jazzpharmaceuticals.com; or Karen L.
Bergman, +1-650-575-1509, or Michelle Corral, +1-415-794-8662, both of BCC
Partners for Jazz Pharmaceuticals, Inc.